RAC 4.05% $1.54 race oncology ltd

Speculative M&A Transaction Analysis, page-812

  1. 19,340 Posts.
    lightbulb Created with Sketch. 6437
    Not as much as the TLX shareholders seem to whinge about CU6. I really don't understand this rivalry between different company shareholders - don't we want to see all Australian biotechs do well. Anyone's success is everyone's success in this space.
    Last edited by Davisite: 06/09/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.